Skip to content

Anesthesia induction in Electroconvulsive therapy for major depressive disorder

Comparison of Etomidate and Sodium Thiopental in anesthesia induction in Electroconvulsive therapy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201104123468N6
Enrollment
60
Registered
2011-04-27
Start date
2009-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent depressive disorder. Recurrent depressive disorder

Interventions

Intervention 1: A group received intravenous sodium thiopental (2.5%, 3mg/kg) . All the patients in both groups received 6 sessions similar bitemporal ECT. Intervention 2: in second group, patients re
Treatment - Other
A group received intravenous sodium thiopental (2.5%, 3mg/kg) . All the patients in both groups received 6 sessions similar bitemporal ECT.
in second group, patients received 0/2 mg/kg etomidate for anesthesia induction and they received ECT for 6 sessions.

Sponsors

Shahid Sadoughi University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: Adult major depressive psychiatric patients 18-50 years ASA=I,II, referred by psychiatrist to take ECT exclusion criteria: discontinue study protocole

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: after 6 sessions of ECT. Method of measurement: Beck Depression Inventory (BDI) score.

Secondary

MeasureTime frame
Seizure duration. Timepoint: each session. Method of measurement: second.;Recovery duration. Timepoint: each session. Method of measurement: minute.;Side effects. Timepoint: each session. Method of measurement: observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hassan Abdollahi

Shahid Sadoughi University of Medical Sciences

mhabdollahi@yahoo.co.uk+98 35 1525 6012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026